CSI Market
Sign In | Register

(HGH) Annual Income Statement

Annual · GAAP · USD millions
Access HGH quarterly income statements →
By examining income statement figures across successive periods, users can identify shifts in 's profitability and expense structure.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2022)
2022 		(Dec 31 2011) (Dec 31 2010) (Dec 31 2007)
Revenues
Sales of Products1,423.00
Total Revenue22,362.00
Costs & Expenses
Cost of Goods and Services Sold1,853.00
Gross Profit0.00
Selling, Administration, Marketing4,830.00
Depreciation & Amortization213.00
Goodwill, Impairment Loss13.00
Total operating costs including COS0.00
Operating income / -loss0.00
Interest Expense0.00
Net Interest (-)Expense / Income0.00
Extinguishment of Debt-9.00
Loss / -Gain on Investment2,177.00
Other loss / -income0.00
Total costs & expenses20,104.00
Income & Taxes
Income / -loss before income taxes2,258.00
Income taxes expenses / -benefit443.00
Income after income taxes1,815.00
Income / -loss from continuing operations1,819.00
Discontinued operations0.00
Preferred dividends21.00
Net income / -loss1,819.00
Income / -loss to shareholder1,798.00
EBIT2,258.00
EBITD2,602.00
EBITDA3,093.00
Earnings Per Share
Basic EPS (excl. extra items)5.52
Extraordinary items0.00
Basic Net EPS5.52
Basic shares outstanding (Mill. of Units)324.80
Diluted Net EPS5.44
Diluted average shares (Mill. of Units)329.50
Dividend per share1.58
4 historic quarters locked

Sign in to unlock the full income statement history.

Sign In Create Free Account
Get the full CSIMarket dataset: Subscribe API License